SPL — Starpharma Holdings Share News
0.000.00%
Last trade - 00:00- AU$221.83m
- AU$211.52m
- AU$12.05m
Brief: Starpharma Holdings Says Signed An Expanded DEP Research Agreement With Genentech
Brief: Starpharma Holdings Says Viraleze To Relaunch In The Uk-Spl.Ax
Australia's Starpharma hits 5-week high on UK relaunch of nasal spray
Australia Stock Exchange release from STARPHARMA HOLDI : Application for quotation of securities - SPL
Brief: Starpharma Confirms It Submitted Application To TGA For Antiviral Nasal Spray As Medical Device
Australia Stock Exchange release from STARPHARMA HOLDI : Response to media article
Australia's Starpharma jumps as nasal spray shows antiviral activity against Omicron
Brief: Starpharma Says SPL7013 Showed Potent Antiviral Activity Against Omicron Variant
Australia Stock Exchange release from STARPHARMA HOLDI : SPL7013 in VIRALEZE virucidal against Omicron
Australia Stock Exchange release from STARPHARMA HOLDI : PRE_NR Ends: 11:38:03
Australia Stock Exchange release from STARPHARMA HOLDI : Dr Jeff Davies appointed as non-executive director
Australia Stock Exchange release from STARPHARMA HOLDI : Interim Report and Half-Year Financial Results
Australia Stock Exchange release from STARPHARMA HOLDI : PRE_NR Ends: 09:43:54
Australia Stock Exchange release from STARPHARMA HOLDI : VIRALEZE distribution in Saudi Arabia - supplementary info
Australia Stock Exchange release from STARPHARMA HOLDI : Change in substantial holding
Brief: Starpharma Holdings Signs Agreement For Viraleze Nasal Spray In Saudi Arabia And 8 Other Countries
Australia Stock Exchange release from STARPHARMA HOLDI : VIRALEZE sales and distribution in Saudi Arabia and GCC
Australia Stock Exchange release from STARPHARMA HOLDI : PRE_NR Ends: 09:42:59
Australia Stock Exchange release from STARPHARMA HOLDI : Application for quotation of securities - SPL